Skip to main content
. 2020 Oct 15;52(10):1754–1765. doi: 10.1038/s12276-020-00514-6

Fig. 3. Overexpression of TGF-β2 in eutopic endometrium and adenomyotic lesions from women with adenomyosis.

Fig. 3

a Semiquantitative analysis of TGF-β2 levels in control endometrium from the proliferative (n = 8) and secretory (n = 13) phases and eutopic endometrium (n = 4 per phase) and adenomyotic lesions (n = 15 per phase) from the proliferative and secretory phases with adenomyosis analyzed by immunohistochemical H-score. The results represent the mean ± SEM. ***p < 0.001. b Representative photomicrographs of immunohistochemical staining of TGF-β2 in women endometrium with (eutopic and adenomyostic lesions) and without adenomyosis during the proliferative and secretory phases. Controls represent the endometrium from women with no history or evidence of adenomyosis. Eutopic refers to the endometrium, and adenomyosis refers to lesions from women with adenomyosis. Scale bars represent 50 μm.